FLT3 and acute myeloid leukemia: Adults with newly diagnosed AML; FLT3–ITD mutation‐positive; in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by single‐agent maintenance therapy